In 1995, in response to the AIDS epidemic, we established the HIV/AIDS Treatment Program (HATP), with Dr. Powel H. Kazanjian as the director. The program provides comprehensive care for the whole person. We utilize a multi-focused team approach that addresses not only the patient's medical needs, but also psychosocial needs. In addition to our Infectious Diseases faculty members who specialize in HIV care, our staff includes a psychiatrist, social workers, medical case managers, a nurse, medical assistants, and a dietician. Today, we follow approximately 900 patients with HIV infection and over 150 additional patients at the Veterans Affairs Ann Arbor Healthcare System.
Mission and Goals
Our HIV/AIDS Treatment Program describes its mission with three goals:
- Provide excellent comprehensive and longitudinal primary and specialty care for all people living with HIV/AIDS.
- Provide education and training along standards of quality related to HIV/AIDS care to other health providers, both within and outside of Michigan Medicine.
- Maintain an active clinical research program, offering expanded access to new and promising treatments for all people living with HIV/AIDS.
Meet the Team
Division of Infectious Diseases Physicians
- Powel Kazanjian, MD, PhD (Medical Director) – Division Chief and Professor of Internal Medicine, Professor of Epidemiology, and Professor of History
- Sandro Cinti, MD – Professor of Internal Medicine
- Tejal Gandhi, MD – Associate Professor of Internal Medicine
- Kevin Gregg, MD – Associate Professor of Internal Medicine
- Daniel Kaul, MD – Professor of Internal Medicine
- James Riddell IV, MD – Professor of Internal Medicine
Department of Psychiatry
- Bradley Stilger, MD – Assistant Professor of Psychiatry
L to R: Charletta Hill, MSW; Samantha Hypes, BSW; Amy Jacobs, LMSW; Lisa Taton-Murphy, BSW
- Charletta Hill, MSW – Clinical Social Worker in Retention to Care
- Samantha Hypes, BSW – Medical Case Manager
- Amy Jacobs, LMSW – Clinical Social Worker
- Lisa Taton-Murphy, BSW – Medical Case Manager
Mark Cichocki, RN – Clinical Nurse
Davina Love Curtis, MA (Left) – Medical Assistant
Heather Simkiss, MA (Right) – Medical Assistant
Laura Garrity, MS, RD – Registered Dietician
Tobacco Treatment Specialist
Carolyn Graham, MS, CHES - Tobacco Cessation Program Coordinator
In the past, we have focused our research efforts on the development of many of the antiretroviral medications that are presently in common use today. Currently, we are working on finding more long- term curative therapies by studying the HIV reservoir. In particular, we are interested in bone marrow stem cells as a reservoir site, as well as immune cells associated with the GI tract. We also are investigating strategies to improve HIV adherence in Mozambique. All of these studies are collaborative in nature and involve large teams leveraging their individual areas of expertise to solve complex problems.
Current Research Study Highlights
- Molecular Mechanisms of HIV Disease Pathogenesis – In this study, we will soon be enrolling volunteers to donate a blood sample, a bone marrow aspirate, and/or a rectal biopsy to study the HIV reservoir in an effort to eventually develop curative treatments.
- Interventions to Improve HIV Antiretroviral Therapy Adherence in Sofala Province Mozambique – People newly diagnosed with HIV infection in Mozambique receive different types of incentives to determine which one improves antiretroviral adherence the most.
- Orphans and Vulnerable Children – Small towns in Mozambique who received government sponsored assistance programs are being evaluated to determine if these programs are effective at increasing HIV testing rates and improving adherence to HIV medications among many other variables being assessed.
- Powel Kazanjian, MD, PhD
- Sandro Cinti, MD
- Tejal Gandhi, MD
- Kevin Gregg, MD
- Daniel Kaul, MD
- James Riddell IV, MD
- Hematopoietic Stem and Progenitor Cells Are a Unique HIV Reservoir That Contribute to Persistent Viremia in Suppressed Patients. Zaikos, TD, Terry, VH, Sebastian Kettinger, NT, Lumbow, J, Painter, MM, Virgilio, MC, Neevel, A, Riddell, J, Bixby, D, Markowitz, N, Taschuk, F, Onafuwa-Nuga, A, McNamara, LA, Colllins, KL. Cell Reports. December 2018.
- 2018 IAS-USA Recommendations for the Use of Antiretroviral Therapy for HIV: Building on Decades of Progress. Riddell J. JAMA. July 2018.
- HIV Preexposure Prophylaxis (PrEP): A Review. Riddell J, Amico KR, Mayer KH. JAMA. March 2018.
- UNAIDS 90-90-90 Campaign to End the AIDS Epidemic in Historic Perspective. Kazanjian, P. Milbank Quarterly. June 2017.
- Reaching High-Risk Patients for HIV Preexposure Prophylaxis. Riddell J, Cohn JA. JAMA. July 2016.
- The AIDS Pandemic in Historic Perspective. Kazanjian, P. Journal of the History of Medicine and Allied Sciences. October 2012.
- Update on Kidney Transplantation into HIV-Infected Recipients. Norman, SP, Kommareddi M, Kaul DR. AIDS Reviews. July-September 2012.
Our HIV/AIDS Treatment Program (HATP) has received funding from the Health Resources and Services Administration’s (HRSA) Ryan White HIV/AIDS Program since 1995. The Ryan White HIV/AIDS Program funds grants to states, cities/counties, and local community-based organizations to provide care and treatment services to people living with HIV to improve health outcomes and reduce HIV transmission among hard-to-reach populations.
Our program currently receives Ryan White HIV/AIDS Program Part C funding from HRSA and Part B funding through the Michigan Department of Health and Human Services (MDHHS). Additionally, MDHHS also funds the HATP for tobacco cessation services. The HATP is funded to provide primary medical care services, mental health services, psychiatric services, nutritional services, medical case management, and emergency financial assistance.
Please visit the HIV/AIDS Treatment Program on UofMHealth.org for more information.
Support Our Work
Making a gift to our program will support our research and understanding of HIV and AIDS in order to advance patient care. To make a gift, please visit the HIV/Aids Education & Research online giving page.